Comparison of in vitro efficacy of linezolid and vancomycin by determining their minimum inhibitory concentrations against methicillin resistant Staphylococcus aureus (MRSA)

Journal of the Pakistan Medical Association

Volumn 61, Issue 4, 2011, Pages 356-359

  Kaleem, Fatima ^a   Usman, Javaid ^a   Khalid, Ali ^a   Hassan, Afreenish ^a   Omair, Maria ^a  

^a NATIONAL UNIVERSITY OF SCIENCES AND TECHNOLOGY   (Pakistan)

Author keywords

Linezolid; Methicillin resistant Staphyloccus aureus; Minumum inhibitory concentrations; Vancomycin

Indexed keywords

LINEZOLID; METICILLIN; VANCOMYCIN;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CONTROLLED STUDY; IN VITRO STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; STAPHYLOCOCCUS AUREUS; VANCOMYCIN RESISTANT STAPHYLOCOCCUS AUREUS;

ACETAMIDES; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; HOSPITALS, MILITARY; HUMANS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; OXAZOLIDINONES; STAPHYLOCOCCAL INFECTIONS; VANCOMYCIN;

EID: 79952741890     PISSN: 00309982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Qureshi AH, Hanan A. The prevalence and susceptibility of pattean of Methicillin Resistant Staphylococus aureus. Pak Armed Forces Med J 2003; 53: 198-201.
2. Perry JD, Davies A, Butterworth LA, Hopley AL, Nicholson A, Gould FK. Development and evaluation of a chromogenic agar medium for methicillinresistant Staphylococcus aureus. J Clin Microbiol 2004; 42: 4519-23.
3. Siddiqui GM, Karamat KA, Hannan A. Prevalence of methicillin resistant Staphylococcus aureus: A study at PAF hospital Sargodha. Pak J Pathol 1999; 10: 26-8.
4. Safdar N, Narans L, Gordon B, Maki DG. Comparison of culture screening methods for detection of nasal carriage of methicillin-resistant Staphylococcus aureus: a Prospective study comparing 32 methods. J Clin Microbiol 2003; 41: 3163-6.
5. Lowy FD. Staphylococcus aureus infections. N Engl J M 1998; 339: 520-32.
6. Blance DS, Wenger A. Bille J. Evaluation of a Novel Medium for Screening Specimens from Hospitalized Patient to Detect Methicillin Resistant Staphylococcus aureus. J Clin Microbiol 2003; 4: 3499-502.
7. Domingues TJ. It's not a spider bite, its community - acquired methicillin - resistant Staphylococcus aureus. J Am Board Fam Pract 2004; 17: 220-6.
8. Mir N, Sanchez M, Baquero F, Lopez B, Calderon C, Canton F. Soft saltmannitol agar-cloxacillin test: a highly specific bedside screening test for detection of colonization with methicillin-resistant Staphylococcus aureus. J Clin Microbiol 1998; 36: 986-9.
9. Perl TM, Cullen JJ, Wenzel RP, Zimmerman MB, Pfaller MA, Shepprad D, et al. Intranasal mupirocin to prevent postoperative Staphylococcus aureus infections. N Engl J M 2002; 346: 1871-7.
10. Hiramatsu K, Hanaki H, Ino T, Yabuta K, Oguri T, Tenover FC. Methicillinresistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. J Antimicrob Chemother 1997; 40: 135-6.
11. Centers for Disease Control and Prevention. Staphylococcus aureus resistant to vancomycin - United States, 2002. MMWR Morb Mortal Wkly Rep 2002; 51: 565-7.
12. Centres for Disease Control and Prevention. Vancomycin-resistant Staphylococcus aureus - Pennsylvania, 2002. MMWR Morb Mortal Wkly Rep 2002; 51: 902.
13. Moreno F, Crisp C, Jorgensen JH, Patterson JE. Methicillin-resistant Staphylococcus aureus as a community organism. Clin Infect Dis 1995; 21: 1308-12.
14. Sanches IS, Ramirez M, Troni H, Abecassis M, Padua M, Tomasz A, et al. Evidence for the geographic spread of a methicillin-resistant Staphylococcus aureus clone between Portugal and Spain. J Clin Microbiol 1995; 33: 1243-6.
15. Hafiz S, Hafiz AN, Ali L, Chughtai AS, Memon B, Ahmed A, et al. Methicillin resistant Staphylococcus aureus: a multicentre study. J Pak Med Assoc 2002; 52: 312-5.
16. Srinivasan A, Dick JD, Perl TM. Vancomycin resistance in Staphylococci. Clin Microbiol Rev 2002; 15: 430-8.
17. Wayne PA. Clinical and Laboratory Standards Institute (CLSI) performance standards for antimicrobial disk diffusion susceptibility tests 19th. Ed., approved standard, CLSI document M100-S19,Vol. 29. CLSI.
18. Weiglt J, Kaaforani HM, Itani KM, Swanson RN. Linezolid eradicates MRSA better than vancomycin from surgical-site infections. Am J Surg 2004; 188: 760-6.
19. Aghazadeh M, Rahbar M, Monnavar MK, Moghadam FS. Sensitivity pattern of methicillin resistant and methicillin sensitive Staphylococcus aureus isolates, against several antibiotics including tigecycline in Iran: A hospital based study. Pak J Med Sci 2009; 25: 443-6.
20. Hannan A, Absar M, Usman M, Naeem T, Saleem S, Muhammad U, Arshad M. In vitro activity of linezolid against clinical isolates of methicillin resistant Staphylococcus. J Ayub Med Coll Abbottabad 2009; 21: 106-9.
21. Kohno S, Yamaguchi K, Aikawa N, Sumiyama Y, Odagiri S, Aoki N, et al. Linezolid versus vancomycin for the treatment of infections caused by methicillin-resistant Staphylococcus aureus in Japan. J Antimicrob Chemother 2007; 60: 1361-9.